Mohammed O
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39976718
DOI: 10.1007/s00210-025-03898-2.
Zhang B, Feng X, Tian L, Xiao B, Hou L, Mo B
Front Immunol. 2025; 16:1519998.
PMID: 39911398
PMC: 11794105.
DOI: 10.3389/fimmu.2025.1519998.
Tian X, Zhang R, Ferro M, Goetz H
Methods Mol Biol. 2024; 2883:139-154.
PMID: 39702707
DOI: 10.1007/978-1-0716-4290-0_6.
Prasad M, Sekar R, Priya M, Varma S, Karobari M
Diagn Pathol. 2024; 19(1):147.
PMID: 39548527
PMC: 11568613.
DOI: 10.1186/s13000-024-01575-1.
Laney V, Hall R, Yuan X, Hampson E, Halle A, Yeung G
Pharm Res. 2024; 41(9):1811-1825.
PMID: 39198318
PMC: 11436418.
DOI: 10.1007/s11095-024-03762-7.
Comprehensive Review of : Development, Bioactive Properties, and Therapeutic Applications.
Sharara A, Badran A, Hijazi A, Albahri G, Bechelany M, Mesmar J
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065699
PMC: 11279937.
DOI: 10.3390/ph17070848.
Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies.
Mitchell M, Khalil M, Ben-Dov I, Alverez-Perez J, Illsley N, Zamudio S
Int J Mol Sci. 2024; 25(10).
PMID: 38791142
PMC: 11121217.
DOI: 10.3390/ijms25105102.
Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer.
Nair M, Mavatkar A, Naidu C, V P S, C E A, Rajarajan S
Cells. 2024; 13(10.
PMID: 38786043
PMC: 11119613.
DOI: 10.3390/cells13100821.
Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.
Martinez-Campa C, Alvarez-Garcia V, Alonso-Gonzalez C, Gonzalez A, Cos S
Cancers (Basel). 2024; 16(5).
PMID: 38473317
PMC: 10931174.
DOI: 10.3390/cancers16050956.
Discovery of novel anaplastic lymphoma kinase (ALK) and histone deacetylase (HDAC) dual inhibitors exhibiting antiproliferative activity against non-small cell lung cancer.
Wang K, Yeh T, Hsu P, Wong T, Liu J, Chern J
J Enzyme Inhib Med Chem. 2024; 39(1):2318645.
PMID: 38465731
PMC: 10930102.
DOI: 10.1080/14756366.2024.2318645.
Role of a Polyphenol-Enriched Blueberry Preparation on Inhibition of Melanoma Cancer Stem Cells and Modulation of MicroRNAs.
Alsadi N, Yahfoufi N, Nessim C, Matar C
Biomedicines. 2024; 12(1).
PMID: 38255297
PMC: 10813708.
DOI: 10.3390/biomedicines12010193.
miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer.
Asante D, Sreekumar A, Nathani S, Lee T, Sharma A, Patel N
Cancers (Basel). 2024; 16(1).
PMID: 38201476
PMC: 10777946.
DOI: 10.3390/cancers16010048.
Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals.
Fakhri S, Moradi S, Abbaszadeh F, Faraji F, Amirian R, Sinha D
Cancer Metastasis Rev. 2024; 43(1):261-292.
PMID: 38169011
DOI: 10.1007/s10555-023-10161-8.
Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells.
Atiya H, Gorecki G, Garcia G, Frisbie L, Baruwal R, Coffman L
Biomolecules. 2023; 13(11).
PMID: 38002286
PMC: 10669774.
DOI: 10.3390/biom13111604.
HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression.
Mardente S, Romeo M, Asquino A, Po A, Gilardini Montani M, Cirone M
Viruses. 2023; 15(10).
PMID: 37896899
PMC: 10612057.
DOI: 10.3390/v15102122.
The circSNX14 functions as a tumor suppressor via the miR-562/ LATS2 pathway in hepatocellular carcinoma cells.
Wu Y, Yang Y, Yi X, Song L
J Mol Histol. 2023; 54(6):593-607.
PMID: 37861952
DOI: 10.1007/s10735-023-10157-2.
Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients.
Raczkowska J, Bielska A, Kretowski A, Niemira M
Front Oncol. 2023; 13:1209299.
PMID: 37546401
PMC: 10401434.
DOI: 10.3389/fonc.2023.1209299.
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs.
Waryah C, Alves E, Mazzieri R, Dolcetti R, Thompson E, Redfern A
Cancers (Basel). 2023; 15(12).
PMID: 37370762
PMC: 10326823.
DOI: 10.3390/cancers15123152.
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies.
Shi Z, Pang K, Wu Z, Dong Y, Hao L, Qin J
Signal Transduct Target Ther. 2023; 8(1):113.
PMID: 36906600
PMC: 10008648.
DOI: 10.1038/s41392-023-01383-x.
LncRNA MALAT1 Regulates Hyperglycemia Induced EMT in Keratinocyte via miR-205.
Zhang L, Hung G, Meng S, Evans R, Xu J
Noncoding RNA. 2023; 9(1).
PMID: 36827547
PMC: 9963368.
DOI: 10.3390/ncrna9010014.